Strategic Global Advisors LLC Purchases New Shares in HCA Healthcare, Inc. $HCA

Strategic Global Advisors LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 8,136 shares of the company’s stock, valued at approximately $3,798,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. State Street Corp raised its holdings in HCA Healthcare by 1.0% during the 4th quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after buying an additional 76,039 shares during the period. Capital World Investors increased its stake in HCA Healthcare by 0.8% in the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after purchasing an additional 40,086 shares during the period. Geode Capital Management LLC increased its stake in HCA Healthcare by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after purchasing an additional 13,565 shares during the period. Norges Bank purchased a new stake in HCA Healthcare in the fourth quarter worth $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership increased its stake in HCA Healthcare by 11.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after purchasing an additional 245,887 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock opened at $387.25 on Monday. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The stock’s 50-day moving average is $429.60 and its 200 day moving average is $473.29. The company has a market cap of $85.91 billion, a P/E ratio of 13.32, a PEG ratio of 1.23 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same period in the previous year, the business earned $6.45 EPS. HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Leerink Partners reduced their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Barclays dropped their price target on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Stephens dropped their price target on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Truist Financial set a $413.00 price target on HCA Healthcare in a research report on Thursday, June 4th. Finally, Oppenheimer dropped their price target on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Fifteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $506.14.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.